Bupropion Hydrochloride
Product Images NDC 70934-225

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70934-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 225 30 Rev A 01 19)

Label (70934 225 30   Rev A 01 19)
This is a package of Bupropion HCI extended-release tablets of 150mg and contains 30 tablets in the package. These tablets are for use with a prescription only and the dosage should be followed as per the instructions on the package. The tablets should be stored between 20-25°C (68"-77°F) and should be kept in the original container. The packaging mentions the lot number and expiry date of the product. These tablets are manufactured by different companies and re-packaged under different names. There seems to be some unclear text at the end of the document.*
FDA Label Image

Chemical Structure (Bupropion Hydrochloride Sr 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.